MedChemExpress
技术文献
- 2025/6/23帕妥株单抗 (anti-HER2)，Pertuzumab (anti-HER2)，380610-27-5，99.10%
- 2025/6/23洛利昔珠单抗，Rozanolixizumab，1584645-37-3，99.34%
- 2025/6/23MR 409，1445155-39-4，99.51%
- 2025/6/23Hepcidin-1 (mouse) (TFA)，98.94%
- 2025/6/23Fluzoparib，氟唑帕利，1358715-18-0，99.96%
- 2025/6/23Butein，紫铆因，487-52-5，99.95%
- 2025/6/23Spliceostatin A，391611-36-2
- 2025/6/23DHX9-IN-1，2973747-89-4，98.33%
- 2025/6/23ML-SA1，332382-54-4，99.44%
- 2025/6/23SR59230A，174689-39-5，≥98.0%
- 2025/6/235β-Cholanic acid，5β-胆烷酸，546-18-9，99.60%
- 2025/6/23ML339，2579689-83-9，99.88%
- 2025/6/23FR900359，107530-18-7，99.90%
- 2025/6/23Elamipretide，736992-21-5，99.89%
- 2025/6/23EZ-482，1016456-76-0
- 2025/6/23STAT6-IN-1，1637532-68-3，99.81%
- 2025/6/23Larazotide acetate，醋酸拉瑞唑来，881851-50-9，99.74%
- 2025/6/23Col003，328565-16-8，99.87%
- 2025/6/23Ebvaciclib，2185857-97-8，99.98%
- 2025/6/23Adenosine monophosphate-15N5 dilithium，腺苷酸-15N5，99.50%
- 2025/6/23Terephthalic acid-13C2，对苯二甲酸 13C2，121191-53-5，99.60%
- 2025/6/23AAA，98.4%
- 2025/6/23PROTAC ERα Degrader-6
- 2025/6/23Ganglioside GM3，124579-05-1，98.07%
- 2025/6/23HB-EGF 蛋白
- 2025/6/23Pariceract，1919820-28-2，98.47%
在线询价
电话咨询